Corpus Intelligence IC Memo — CALVERT MEMORIAL HOSPITAL 2026-04-26 06:40 UTC
IC Memo — CALVERT MEMORIAL HOSPITAL
Investment Committee Memorandum | MD | 78 beds | Grade B | EBITDA uplift $11.0M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

CALVERT MEMORIAL HOSPITAL

CCN 210039 | CALVERT, MD | 78 beds | April 26, 2026
EBITDA BridgeData Room
B
Investability

1. Target Overview & Investment Thesis

CALVERT MEMORIAL HOSPITAL is a 78-bed suburban community hospital in CALVERT, MD with $150.0M in net patient revenue and a -7.2% operating margin. The hospital serves a payer mix of 48.4% Medicare, 7.2% Medicaid, and 44.4% commercial.

Thesis: Turnaround. Our ML models identify $11.0M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -7.2% to 0.2% (+736bps).

Net Revenue HCRIS$150.0M
Current EBITDA COMPUTED$-10.8M
Operating Margin COMPUTED-7.2%
Occupancy HCRIS76.7%
Revenue / Bed COMPUTED$1.9M
Net-to-Gross HCRIS82.8%
Distress Probability ML48.3%

2. Market Context & Competitive Position

59
MD Hospitals
-8.3%
State Median Margin
20
Comparable Hospitals

MD has 59 Medicare-certified hospitals with a median operating margin of -8.3%. The target's margin of -7.2% places it above the state median. Among 20 size-comparable peers (39-156 beds), the median margin is -3.1%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (39-156), prioritizing same-state peers. 20 hospitals in the comp set.

HospitalStateBedsRevenueMargin
CALVERT MEMORIAL HOSPITAL (Target)MD78$150.0M-7.2%
MEMORIAL EASTONMD143$287.6M-4.1%
KENNEDY KRIEGERMD50$203.5M-50.0%
ST. MARYS HOSPITALMD105$198.5M-1.5%
UNION HOSPITAL OF CECIL COUNTYMD124$184.1M-4.6%
MEDSTAR HARBOR HOSPITALMD142$178.3M-13.3%
MEDSTAR MONTGOMERY MEDICAL CENMD96$173.7M-14.1%
CIVISTA MEDICAL CENTERMD98$154.9M2.9%
ATLANTIC GENERAL HOSPITALMD62$148.6M-12.0%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $11.0M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$3.1M+210bp18mo
Cost to Collect4.5%2.5%$3.0M+200bp12mo
Denial Rate Reduction12.0%6.5%$3.0M+198bp12mo
A/R Days Reduction5200.0%3800.0%$1.8M+122bp9mo
Clean Claim Rate88.0%96.0%$96K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$3.1M
Cost to Collect
$3.0M
Denial Rate Reduction
$3.0M
A/R Days Reduction
$1.8M
Clean Claim Rate
$96K
Total EBITDA Uplift$11.0M
Current EBITDA$-10.8M
+ RCM Uplift+$11.0M
Pro Forma EBITDA$233K
Current Margin-7.2%
Pro Forma Margin0.2%
WC Released (1x)$5.8M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-16.6M$39.1M0.00x-100.0%
Base (11x exit)10.0x11.0x$-16.6M$37.6M0.00x-100.0%
Bull Case9.0x11.0x$-15.0M$68.6M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-15.0M$70.5M0.00x-100.0%
Bear Case11.0x10.0x$-18.3M$-10.7M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-18.3M$-17.7M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 20 hospitals with 39-156 beds
  • Same-state prioritization (n=21)
  • Comp margins: P25=-13.5% / P50=-3.1% / P75=1.0%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.